RNF8-CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer.

J Pers Med · 2021 · PMC8307233 · PMID 34357122

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

As it is shown in Figure 5 A, RNF8 high / CDH1 low showed a strong trend of poor PFS when compared to RNF8 low -medium / CDH1 medium -high in patients receiving chemotherapy alone.

also in 5,725 other papers

showed a trendno p-value reported

It is worth noting that RNF8 high / CDH1 low showed a trend of poor DFS when compared to RNF8 high / CDH1 medium-high .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.